These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18986369)

  • 1. Lack of efficacy of topical imiquimod in the treatment of patchy alopecia areata.
    Koc E; Tunca M; Akar A; Kurumlu Z
    Int J Dermatol; 2008 Oct; 47(10):1088-9. PubMed ID: 18986369
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of the topical sensitizer squaric acid dibutyl ester in Alopecia areata and factors influencing the outcome.
    Ajith C; Gupta S; Kanwar AJ
    J Drugs Dermatol; 2006 Mar; 5(3):262-6. PubMed ID: 16573260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of flat warts with 5% imiquimod cream.
    Kim MB; Ko HC; Jang HS; Oh CK; Kwon KS
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1349-50. PubMed ID: 17062069
    [No Abstract]   [Full Text] [Related]  

  • 4. Topical application of imiquimod and associated fever in children.
    Campanelli A; Krischer J; Saurat JH
    J Am Acad Dermatol; 2005 Jan; 52(1):E1. PubMed ID: 15627071
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mood changes in patients on topical imiquimod].
    Brenaut E; Coquart N; Garlantezec R; Herault M; Schoenlaub P
    Ann Dermatol Venereol; 2012 Feb; 139(2):145-8. PubMed ID: 22325757
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of adenopathy during the use of topical imiquimod.
    Anadkat MJ; Bogucki BA
    J Am Acad Dermatol; 2011 May; 64(5):e75-7. PubMed ID: 21496688
    [No Abstract]   [Full Text] [Related]  

  • 7. Possible advantage of imiquimod and diphenylcyclopropenone combined treatment versus diphenylcyclopropenone alone: An observational study of nonresponder patients with alopecia areata.
    Wasyłyszyn T; Borowska K
    Australas J Dermatol; 2017 Aug; 58(3):219-223. PubMed ID: 27087586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of topical sensitizers in the treatment of alopecia areata.
    Rokhsar CK; Shupack JL; Vafai JJ; Washenik K
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):751-61. PubMed ID: 9810892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical imiquimod.
    Pearson GW; Langley RG
    J Dermatolog Treat; 2001 Mar; 12(1):37-40. PubMed ID: 12171687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Imiquimod creme 5 per cent--a new agent for topical treatment of external condylomata].
    Petersen CS; Veien NK
    Ugeskr Laeger; 1999 Nov; 161(46):6368-70. PubMed ID: 10611839
    [No Abstract]   [Full Text] [Related]  

  • 11. Pyogenic granuloma in children: treatment with topical imiquimod.
    Fallah H; Fischer G; Zagarella S
    Australas J Dermatol; 2007 Nov; 48(4):217-20. PubMed ID: 17956478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychiatric symptoms associated with topical imiquimod therapy: report of 2 cases.
    Brett AS; Voss T; Ridley EP
    JAMA Dermatol; 2013 Apr; 149(4):500-1. PubMed ID: 23715381
    [No Abstract]   [Full Text] [Related]  

  • 13. Topical and intralesional therapies for alopecia areata.
    Alkhalifah A
    Dermatol Ther; 2011; 24(3):355-63. PubMed ID: 21689245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discoid lupus erythematosus exacerbated by contact dermatitis caused by use of squaric acid dibutylester for topical immunotherapy in a patient with alopecia areata.
    Shimaoka Y; Hatamochi A; Hamasaki Y; Suzuki H; Ikeda H; Yamazaki S
    J Dermatol; 2008 Mar; 35(3):151-3. PubMed ID: 18346258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical sensitizers in alopecia areata.
    McMichael AJ; Henderson RL
    Dermatol Nurs; 2004 Aug; 16(4):333-6. PubMed ID: 15471045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Bowen's disease with topical 5% imiquimod cream: retrospective study.
    Rosen T; Harting M; Gibson M
    Dermatol Surg; 2007 Apr; 33(4):427-31; discussion 431-2. PubMed ID: 17430376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local and systemic adverse effects to topical imiquimod due to systemic immune stimulation.
    Kumar B; Narang T
    Sex Transm Infect; 2011 Aug; 87(5):432. PubMed ID: 21606474
    [No Abstract]   [Full Text] [Related]  

  • 18. Imiquimod reactivation of lichen planus.
    Domingues E; Chaney KC; Scharf MJ; Wiss K
    Cutis; 2012 Jun; 89(6):276-7, 283. PubMed ID: 22838091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% imiquimod cream in the treatment of actinic keratosis.
    Kose O; Koc E; Erbil AH; Caliskan E; Kurumlu Z
    J Dermatolog Treat; 2008; 19(3):159-63. PubMed ID: 18569272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of focal epithelial hyperplasia with topical imiquimod: report of three cases.
    Yasar S; Mansur AT; Serdar ZA; Goktay F; Aslan C
    Pediatr Dermatol; 2009; 26(4):465-8. PubMed ID: 19689526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.